Attacks On Private ...
Consumer Goods: Consumer Non-Durables
Rogers Corporation (ROG: NYSE)
$40.49 -0.78 | -1.89%
02/10/12 - 11:44 AM ET
9.25K / 122.50K
Vol / Avg. Vol:40.71 / 41.27
Open / Prev. Close:40.36 - 40.92
Today's Range:32.19 - 52.44
52 Wk Range:11.96%
Performance YTD:TheStreet Rating:
Portfolios with ROG
- Portfolio NameUser Type
- ProWestport Asset Management
- ProVanguard PRIMECAP - VPMCX
- ProRoyce Heritage Service - RGFAX
- ProLord Abbett Small-Cap Value...
- ProJanus Adviser Forty (JARTX)
- Useredlwhite Portfolio 1
- UserConfer Calls May/June 08 Ny...
- ProLord Abbett Small-Cap Value...
- ProExcelsior Small Cap - UMLCX
- ProLord Abbett Small-Cap Value...
Latest ROG Headlines from TheStreet
- Company Earnings Are About to Get a Lot Uglier in 2012 01.05.12 | 12:01 pm
- Rogers Reaches New 52-Week High (ROG) 08.02.11 | 10:08 am
- Rogers Reaches New 52-Week High (ROG) 07.22.11 | 02:07 pm
- Rogers Stock Hits New 52-Week High (ROG) 07.07.11 | 10:07 am
- Rogers Stock Hits New 52-Week High (ROG) 02.28.11 | 10:02 am
- Rogers Stock Hits New 52-Week High (ROG) 02.18.11 | 09:02 am
- NYSE Stocks Posting Largest Percentage Decreases 11.02.10 | 05:11 pm
- NYSE Stocks Posting Largest Percentage Decreases 11.02.10 | 01:11 pm
- Rogers CEO Discuses Q3 2010 Results - Earnings Call Transcript 11.02.10 | 01:11 pm
- Rogers Corporation Q2 2010 Earnings Call Transcript 08.03.10 | 12:08 pm
Press Releases for ROG
- Rogers Corporation Invites You To Join Its 2011 Fourth Quarter And Year-End Earnings Conference Call - Business Wire 02.09.12 | 10:02 am
- Roche Disappointed By The Actions Of Illumina, Inc.’s Board Of Directors - Business Wire 02.08.12 | 01:02 am
- FDA Grants Genentech’s Pertuzumab Priority Review For Previously Untreated HER2-Positive Metastatic Breast Cancer - Business Wire 02.07.12 | 12:02 pm
- Roche Receives FDA Clearance For Test To Screen And Diagnose Chlamydia And Gonorrhea Infection In Symptomatic And Asymptomatic Patients - PR Newswire 02.01.12 | 09:02 am
- Roche To Nominate Slate Of Independent Directors For Election At Illumina, Inc.’s 2012 Annual Meeting - Business Wire 01.31.12 | 12:01 pm
- FDA Approves Erivedge (Vismodegib) Capsule, The First Medicine For Adults With Advanced Basal Cell Carcinoma - Business Wire 01.30.12 | 11:01 am
- Roche Commences Tender Offer For Illumina, Inc. For $44.50 Per Share In Cash - Business Wire 01.27.12 | 11:01 am
- Roche Responds To Adoption Of Shareholder Rights Plan By Illumina Board Of Directors - Business Wire 01.26.12 | 06:01 pm
- Roche To Host Investor Conference Call Regarding Offer For Illumina, Inc. - Business Wire 01.24.12 | 10:01 pm
- Roche Offers To Acquire All Outstanding Shares Of Illumina, Inc. To Further Strengthen Its Leading Role In Diagnostics - Business Wire 01.24.12 | 09:01 pm
Partner Headlines for ROG
- UPDATE 1-U.S. VA to halt Avastin use for eye disease-report - Reuters 09.21.11 | 02:09 pm
- Hoechner to Receive Equity Inducement Awards - Benzinga 09.21.11 | 01:09 pm
- Hoechner Named President and Chief Executive Officer of Rogers Corporation - Benzinga 09.21.11 | 01:09 pm
- Roche stops deliveries to some Greek hospitals-WSJ - Reuters 09.16.11 | 08:09 pm
- Moves from American Superconductor - Analyst Blog - Zacks 08.12.11 | 05:08 pm
- CORRECTED-US approval of Roche melanoma drug may come early - Reuters 08.10.11 | 01:08 pm
- US approval of Roche melanoma drug may come early - Reuters 08.09.11 | 10:08 am
- UPDATE 1-Medicare will keep covering Roche's Avastin - Reuters 06.30.11 | 01:06 pm
- Medicare will keep covering Roche's Avastin-CMS - Reuters 06.30.11 | 01:06 pm
- UPDATE 4-US FDA panel rejects Avastin for breast cancer use - Reuters 06.29.11 | 05:06 pm
